High ERCC1 expression is associated with platinum-resistance, but not survival in patients with epithelial ovarian cancer

The present study aimed to investigate the association between excision repair cross-complementation group 1 (ERCC1) expression and clinical resistance to platinum-based chemotherapy or clinical characteristics, including survival time, in patients with epithelial ovarian cancer (EOC). ERCC1 express...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Pei, Wang, Yifeng, Chen, Liquan, Gan, Yaping, Wu, Qinian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950824/
https://www.ncbi.nlm.nih.gov/pubmed/27446360
http://dx.doi.org/10.3892/ol.2016.4732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950824/
https://www.ncbi.nlm.nih.gov/pubmed/27446360
http://dx.doi.org/10.3892/ol.2016.4732

Ejemplares similares